Benlysta (belimumab) - GSK
hydroxychloroquine - Generic mfg.
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Rituxan (rituximab) - Biogen, Zenyaku Kogyo, Roche
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
Success story of a challenging case of refractory lupus nephritis (NKF-SCM 2023) - Feb 18, 2023 - Abstract #307; Location: Exhibit Hall; "We present the first case to our knowledge of successful achievement of remission in refractory LN with voclosporin in combination with cyclophosphamide (CYC) induction.Methods A 30-year-old female with SLE presented following pregnancy with 3 g/day proteinuria...She was treated with MMF and remained on maintenance hydroxychloroquine...She underwent repeat induction with Euro-lupus regimen, received two doses of rituximab and was maintained on prednisone and MMF but leukopenia limited dose escalation...Prior allergic reaction excluded the opportunity to use belimumab...Concomitant use of CYC and voclosporin is a potential viable treatment option in refractory LN as illustrated in our patient. Further studies are needed to gain more experience with this strategy." 
Clinical • Acute Kidney Injury • Allergy • Chronic Kidney Disease • Glomerulonephritis • Hematological Disorders • Immunology • Inflammatory Arthritis • Leukopenia • Lupus • Lupus Nephritis • Nephrology • Renal Disease
https://casehippo.com/spa/courses/resource/2023-spring-clinical-meetings/event/home/posters/abstracts?abstractId=2397
 
David Brooker1; Randa Abd Algayoum1; Swati Arora1
 
Feb 18, 2023
 
Prev Next